Business Context and Reporting Period
This Form 8-K filing by TherapeuticsMD, Inc. (Nasdaq: TXMD) was submitted on April 21, 2023. The report announces the scheduling of the combined 2022 and 2023 Annual Meeting of Stockholders, noting that no annual meeting was held in 2022.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events rather than a financial statement.
Material Changes
There are no material financial changes reported in this filing. The primary event is the administrative scheduling of the Annual Meeting to address the missed 2022 meeting.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: Monday, June 19, 2023.
- Record Date: April 20, 2023 (shareholders of record on this date are entitled to vote).
- Proposal Deadlines: The deadline for stockholder proposals under Rule 14a-8 and for director nominations or other business under the Bylaws is May 1, 2023, at 5:00 p.m. Eastern Time.
- Proxy Statement: Additional details regarding the meeting agenda and voting matters will be included in a proxy statement to be filed with the SEC prior to the meeting.
Investor Verification Checklist
- Verify the record date of April 20, 2023, to confirm voting eligibility.
- Monitor the upcoming proxy statement for specific agenda items and voting instructions.
- Note the May 1, 2023, deadline for submitting stockholder proposals or director nominations.
- Confirm the physical address for submitting notices: 951 Yamato Road, Suite 220, Boca Raton, FL 33431.